Extended Data Table 2 Summary of exposure to cadonilimab in all treated participants

From: Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial

  1. aActual dose intensity is the actual cumulative dose (mg) / (exposure duration (days) / days of cycle).
  2. bRelative dose intensity is the actual dose intensity (mg per cycle) / planned dose intensity (mg per cycle) × 100.
Back to article page